iTeos Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
iTeos Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q2 2024.
  • iTeos Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -15.9 %, a 314% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Return On Assets for 2023 was -16.2 %, a 234% decline from 2022.
  • iTeos Therapeutics, Inc. annual Return On Assets for 2022 was 12.1 %, a 65.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -15.9 -12 -314% Apr 1, 2024 Jun 30, 2024
Q1 2024 -20.2 -21.7 -1449% Jan 1, 2024 Mar 31, 2024
Q4 2023 -16.2 -28.3 -234% Oct 1, 2023 Dec 31, 2023
Q3 2023 -8.61 -40 -127% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.83 -41.8 -110% Apr 1, 2023 Jun 30, 2023
Q1 2023 1.5 -38.5 -96.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 12.1 -22.8 -65.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 31.4 +28.3 +921% Jul 1, 2022 Sep 30, 2022
Q2 2022 38 +57.5 Apr 1, 2022 Jun 30, 2022
Q1 2022 40 +55.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 34.9 Oct 1, 2021 Dec 31, 2021
Q3 2021 3.07 Jul 1, 2021 Sep 30, 2021
Q2 2021 -19.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -15.8 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.